InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,408.42
(
-1.73%
)
US TECH 100
17,870.94
(
-3.09%
)
Dow Jones
40,345.41
(
-1.01%
)
Brent Oil
70.89
(
0.00%
)
Bitcoin
53,838.33
(
-0.62%
)

Replies to post #142208 on Biotech Values

Replies to #142208 on Biotech Values
icon url

DewDiligence

05/18/12 7:03 PM

#142236 RE: mcbio #142208

Lyxumia looks like a strong competitor based on the five phase-3 trials reported in #msg-63710626 and the embedded links in the prologue of that post. Sorry, I have no info on the economics of SNY’s license from Zealand Pharma.